SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| LEO Pharma A/S | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Medium | 5 | Jun 4, 2026 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2035 Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year 2050 Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location Denmark Company Size Medium Target Statement Overall Net-Zero Target: LEO Pharma A/S commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: LEO Pharma A/S commits to reduce absolute scope 1 and 2 GHG emissions 63.0% by 2035 from a 2024 base year. LEO Pharma A/S also commits… Stakeholders Celina Tidemand Lindeneg Global Sustainability Manager, Lead Scope 3 & Sustainable Procurement Christina Dahl Head of Sustainability and Public Affairs France Bourgouin Director, Global Sustainability Kristian Sibilitz Executive Vice President, Product Supply Nathalie Daste Executive Vice President, Global People and Corporate Affairs | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.